Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001064190 | SCV001229073 | likely benign | Tuberous sclerosis 2 | 2024-12-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002402447 | SCV002713592 | likely benign | Hereditary cancer-predisposing syndrome | 2022-08-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV004000140 | SCV004833954 | likely benign | Tuberous sclerosis syndrome | 2023-07-10 | criteria provided, single submitter | clinical testing | |
Ce |
RCV004720746 | SCV005329899 | uncertain significance | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | TSC2: PM2, BP4 |